9 Liver Disease Clinical Trials in Chandler, AZ (2026)

Q: How do I join a clinical trial in Chandler?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chandler research site will contact you.

Recruiting Liver Disease Studies in Chandler

NCT07165028Recruiting

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in people with high-risk metabolic dysfunction-associa...

Chandler, AZ4,500 participantsEli Lilly and Company

View Study Details

NCT06528314Recruiting

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NASH/MASH....

Chandler, AZ2,150 participantsAkero Therapeutics, Inc

View Study Details

NCT06318169Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin for the treatment of liver fibrosis stage 2 or 3 in adult participants with MASH (previously known as nonalcoholic stea...

Chandler, AZ1,350 participants89bio, Inc.

View Study Details

NCT06613698Recruiting

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease

The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease....

Chandler, AZ393 participantsGlaxoSmithKline

View Study Details

NCT06836609Recruiting

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

This study is researching an experimental drug called ALN-CIDEB, also referred to as "study drug". The study is focused on participants with metabolic dysfunction-associated steatotic liver disease (M...

Chandler, AZ132 participantsRegeneron Pharmaceuticals

View Study Details

NCT07610837Recruiting

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

The purpose of this study is to evaluate the safety, tolerability, and pharmacodynamic effects of AZD2389 in adult participants with steatotic liver disease (SLD) and advanced fibrosis....

Chandler, AZ104 participantsAstraZeneca

View Study Details

NCT05490888Recruiting

Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics

This 2-part study will evaluate PHIN-214 given as a single one-time dose (Part 1) and in multiple doses (given as daily doses for 28-days) (in Part 2). Specifically, this study evaluates PHIN-214, to ...

Chandler, AZ74 participantsPharmaIN

View Study Details

NCT06920043Recruiting

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis...

Chandler, AZ42 participantsBoston Pharmaceuticals

View Study Details

NCT07325526Recruiting

A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

This study is open to adults with a type of confirmed liver condition called compensated cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH). The purpose of this study is to find ...

Chandler, AZ29 participantsBoehringer Ingelheim

View Study Details

About Liver Disease Clinical Trials in Chandler

Chronic liver disease encompasses conditions that damage the liver over time, including cirrhosis, hepatitis, and fatty liver disease. The liver plays a crucial role in digestion, metabolism, and detoxification. Treatment depends on the cause and may include medications, lifestyle changes, or liver transplant.

There are currently 9 liver disease clinical trials recruiting participants in Chandler, AZ. These studies are seeking a combined 8,774 participants. Research is being sponsored by Eli Lilly and Company, Akero Therapeutics, Inc, 89bio, Inc. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Liver Disease Clinical Trials in Chandler — FAQ

Are there liver disease clinical trials in Chandler?

Yes, there are 9 liver disease clinical trials currently recruiting in Chandler, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chandler?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chandler research site will contact you about next steps.

Are clinical trials in Chandler free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chandler studies also compensate for your time and travel.

What liver disease treatments are being tested?

The 9 active trials in Chandler are testing new therapies including novel drugs, biologics, and treatment approaches for liver disease.

Data updated July 13, 2026 from ClinicalTrials.gov